Last reviewed · How we verify
influenza vaccine Fluarix, Adjuvanted Fluarix
influenza vaccine Fluarix, Adjuvanted Fluarix is a Biologic drug developed by GlaxoSmithKline. It is currently in Phase 1 development.
At a glance
| Generic name | influenza vaccine Fluarix, Adjuvanted Fluarix |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) (PHASE1)
- Influenza Vaccination Strategy for Patients With Hematologic Malignancy (PHASE3)
- A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age (PHASE3)
- A Study of Modified mRNA Vaccines in Healthy Adults (PHASE1)
- Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines (NA)
- Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients (PHASE2)
- Vaccine Responses in Patients With B Cell Malignancies (PHASE4)
- WU 345: Immune Responses to Adjuvanted and Non-adjuvanted Seasonal Influenza Vaccines in the Lymphoid Tissues. (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- influenza vaccine Fluarix, Adjuvanted Fluarix CI brief — competitive landscape report
- influenza vaccine Fluarix, Adjuvanted Fluarix updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about influenza vaccine Fluarix, Adjuvanted Fluarix
What is influenza vaccine Fluarix, Adjuvanted Fluarix?
influenza vaccine Fluarix, Adjuvanted Fluarix is a Biologic drug developed by GlaxoSmithKline.
Who makes influenza vaccine Fluarix, Adjuvanted Fluarix?
influenza vaccine Fluarix, Adjuvanted Fluarix is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).
What development phase is influenza vaccine Fluarix, Adjuvanted Fluarix in?
influenza vaccine Fluarix, Adjuvanted Fluarix is in Phase 1.